Wednesday, 13th November Clinical Oncology Society of Australia Annual Scientific Meeting 2019

Chair: Kim Hobs

Speaker: Matt Loscalzo  

Chair: Mei Krishnasamy 

Speaker: Lena Sharp 

• My Health Record and beyond: Harnessing the modern information revolution - Angela Ryan
• If PROs were a drug, the public would demand immediate implementation! The case for PROs reducing costs and variations in care - Afaf Girgis
• How can mobilization of health data and application of AI inform decision making in cancer care?  - Tim Shaw
• Issues and limitations that arise with digital health  - Trish Williams

10:00 AM Panel Discussion

• The promise and peril of social media for clinicians, researchers and patients - Stacy Loeb
• Implementing digital health for assessing and responding to clinical anxiety and depression (ADAPT)  - Phyllis Butow
• Using digital behaviour change tools to help cancer survivors adopt and maintain regular exercise  - Camille Short
• Web-based psychological interventions for cancer-related distress - Lisa Beatty
• Using virtual reality as a clinical tool  - Belinda Lange

• Medicines in paediatric oncology – A family matter - Hayley Vasileff
• Engaging Adolescent and Young Adult (AYA) Cancer Patients: Challenges or Opportunities?  - Alexandre Chan
• Medicine(s) Matter(s) in the Older Patient: Understanding, Counselling and Health Literacy  - Jenny Casanova
• Mastering patient education - Lisa McLean

12:20 PM Panel Discussion 

• Introduction: End of life care is about more than euthanasia   - Peter Allcroft
• Organisational readiness for legislated VAD - Reflections on the lessons learnt and experience gained - Mark Boughey
• Voluntary Assisted Dying: How does palliative care respond?  - Helen Walker
• Experience implementing VAD in Victoria - Speaker TBC

11:55 AM Panel Discussion

Panel:

Dr Peter Allcroft, Palliative care

Ms Peggy Briggs, Cancer nursing

A/Prof Alexandre Chan, Cancer pharmacy

Dr Eunice Dai, Medical oncology

Prof Jon Emery, Primary care

Prof Matt Loscalzo, Supportive Care

Prof Ian Olver AM, Medical ethics

• Genomic HLA heterozygosity as a predictive marker for response to immunotherapy in both lung cancer and melanoma patients. - Afaf Abed
• Lung cancer treatment mapping: a retrospective audit of clinical practice at Peninsula Health - Aaron Bagnato
• Safe administration of Anti-PD1 immunotherapy in a patient with pre-existing Autoimmune Hepatitis - Prachi Bhave
• Patterns of care for metastatic pancreatic cancer in Australian practice. - Amy Body
• Use and impact of perioperative chemotherapy in patients with resected colorectal cancer metastases. - Amy Body
• Patterns of Immunotherapy use and management of toxicities in a regional cancer centre - Yamamah Y Idrees
• Sleep disturbance and alcohol use in breast cancer survivors attending Sydney Survivorship Centre - Emma Carson
• Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis - Sahan D Chandrasekara
• Study Evaluating the Impact of AI Software to Identify and Validate Patients for Clinical Trials - Rachael Chang Lee
• Metformin and Statin in Men with Biochemically Recurrent Prostate Cancer (BCRPC) - Julia Chen
• A Novel Delivery Mechanism for Cannabinoids in Pain Management - Stephen Clarke
• Predictors of severe gastrointestinal toxicity risk in patients treated with 5-fluorouracil-based chemotherapy: a validation study - Janet K Coller
• Retrospective Analysis of Metastatic Melanoma Treatment Outcomes in the Young and Elderly Populations - Thomas Conrad
• A Closer Look at Immune Checkpoint Inhibitor-Mediated Myocarditis in the Era of Combined Checkpoint Blockade and Targeted Therapies - Youseph Dib
• Cancer Diagnoses following Abnormal Cell-Free DNA Detected via Non-Invasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model - Eryn Dow
• Drug induced physiologic changes and response to cancer therapies: Focus on immune checkpoint inhibitors and antibiotics in advanced melanoma - Mitchell Dyer
• Mortality within 30 days of receiving checkpoint inhibitor immunotherapy in an Australian regional cancer centre. - James Fletcher
• Survival outcomes for BRAF wild type advanced melanoma treated with first line immunotherapy in a regional cancer centre: experience from the Liz Plummer Cancer Centre. - James Fletcher
• Australasian Merkel Cell Carcinoma Interest Group (AMIGOs) – improving the outlook for patients with Merkel cell carcinoma - Junya Eguchi
• Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancer - Monique Gadd
• Postoperative nutritional support for right colon cancer elderly patients undertook laparoscopic radical right hemicolectomy - Ke Gong
• Update on Overall Survival in COLUMBUS: A Randomized Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) vs Vemurafenib (VEM) or ENCO in Patients With BRAF V600–Mutant Melanoma - Andrew Haydon
• A Victorian clinician-based survey on current practices for breast cancer staging in pregnancy - Harriet Herbison
• Xentuzumab (BI 836845), an IGF-neutralizing antibody, combined with exemestane and everolimus in hormone receptor-positive (HR+) locally advanced/metastatic breast cancer: Randomized Phase 2 results - Dennis Chin-Lun Huang
• A real world study on adjuvant nivolumab: recurrence free survival and toxicity in resected stage III and IV melanoma - Wendy E Huang
• Impact of Carboplatin Dosing Guideline on Variation in Practice around Dose Adjustment from changes in Patients’ Renal Function and Weight - Shiu Wei Kan
• Psychological/behavioural comorbidities are more common among lung cancer patients than colorectal cancer patients in a regional Victorian hospital setting - Michael Leach
• Consumer Driven Priority setting - a practical example: Are iron deficiency, oxaliplatin and neuropathy linked? - Julie Marker
• Phase I study of NOX66 in combination with radiotherapy in patients with late-stage metastatic castrate resistant prostate cancer (DARRT-1 Study) - Gisela Mautner
• Lenvatinib in metastatic radioiodine refractory thyroid cancer - a single centre experience - Michael McLucas
• A phase II randomised control trial of high dose vitamin D in localised low risk prostate cancer patients with intermediate risk of disease progression –ProsD - Visalini Nair-Shalliker
• Cerebral blood flow during high-intensity interval exercise in breast cancer survivors - Joseph M Northey
• Investigating the effects of nutritional status on post-operative complications in a head and neck cancer surgical population - Alice Pashley
• Clinical predictors of survival in real world practice in Stage IV melanoma - Hsien-Pang Hu
• AL-study – A pilot study of Traditional Chinese Herbal medicines Astragalus membranaceus and Ligustrum lucidum in people with advanced malignancy - Thi TD Pham
• Comprehensive audit of baseline investigations and subsequent management of patients with breast cancer at Peninsula Health - Sruti Pillai
• A phase I study of oncolytic immunotherapy of metastatic neuroendocrine tumors using intralesional rose bengal disodium: Cohort 1 results. - TimothyTimothy Price
• Assessing the Quality of Care in Breast Cancer Radiotherapy - Sara SP Pyun
• ClinTrial Refer. One Integrated Platform. Global Searching. - Christine Zahren
• Avelumab treatment of metastatic Merkel cell carcinoma (mMCC): updated findings from Australian patients enrolled in an expanded access program (EAP) - Belinda Lee
• iPREDICT: Incorporating complex profiling of patients to enrol onto molecularly directed cancer therapeutics.  Preliminary results of the adult and paediatric cohorts. - Kortnye Smith
• Multidisciplinary meeting case discussion, palliative care referral and end-of-life outcomes in lung cancer: A retrospective study - Krita Sridharan
• Taste and saliva changes in long term survivors of head and neck cancer and their impact on quality of life post therapy: A qualitative study. - Nadiah Tadjoudine
• Analysis of overall survival (OS) based on early tumour shrinkage in the phase 3 METEOR study of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC) - T H Tan
• Metastatic Primary Breast Neuroendocrine Neoplasms: A Case Series - Amelia Taylor
• Quality of evidence and clinical benefit of cancer medicines evaluated for funding in Australia   - Agnes I Vitry
• The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies - Brooke E Wilson
• Quantitative measures of salivary changes in head and neck cancer survivors post definitive chemotherapy and radiotherapy - Ke Xu
• Correlation of Primary Melanoma Tumour Mitotic Count and Tumour Infiltrating Lymphocytes with Response to Immunotherapy - Andrew Haydon
• A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): updated results - Louise Young
• Cetuximab anaphylaxis and tick bites – a rare but important association for patients living in high tick prevalence areas. - Alexander Yuile
• A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor (GCSF) on febrile neutropenia (FN) rates in (neo)adjuvant breast cancer chemotherapy regimens. - Girish Mallesara
• Life-threatening Diarrhoea in Neuroendocrine Tumours: Two Case Reports to Illustrate Management Issues - David Chan
• Implementation of an immune-related adverse events (irAE) education program for healthcare professionals at an Australian multisite tertiary health service. - Amy Davies
• Pharmacists’ role in identifying uncommon endocrinopathies associated with immune checkpoint inhibitors. - Sarah Mackenzie
• Ovarian cancer experiential learning initiative - Survivors Teaching Students: Saving Women’s Lives® (STS) benefits both health professional students and ovarian cancer survivors. - Helen Gooden
• Improving management of family conflict, anger and dominance: Evaluation of an online education module for McGrath Breast Care Nurses - Ilona Juraskova
• Effective ways to engage general practice: lessons learnt from the IPACED ME project - Joanna Ong
• Click – Connect – Converse – Collaborate.  Extending the reach of education and professional development opportunities through webinar series - Elizabeth Zwart
• Feasibility of the electronic Rapid Fitness Assessment (eRFA) in an Australian Regional Cancer Centre - Ayman A Alidina
• Exploring Knowledge and Attitudes in Cancer Tumor Genomic Profiling - Megan C Best
• Development of a complementary medicines and anticancer agent interaction tool   - Sally L Brooks
• Incidence and severity of scanxiety in people with advanced solid cancers: results from a multicentre questionnaire - Kim Tam Bui
• Evaluation and comparison of the emetogenicity of intravenous and intramuscular erwinia asparaginase in children and adolescents with leukaemia - Hayley Vasileff
• Optimising the cancer nutrition path: exploring patient and carers experiences of nutrition in cancer care - Sarah Dewar
• Does a prescribed, supervised exercise program correlate with better disease progression outcomes in oncology patients who are on active anti-cancer treatments? A retrospective observational cohort study - Daniella Dougherty
• Prognostic models for predicting ovarian function in young breast cancer patients after chemotherapy: a systematic review and meta-analysis. - Zobaida Edib
• Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre.  - Hugh Elbourne
• RESTORE: A web-based intervention supporting the self-management of cancer related fatigue. - Claire Foster
• Cohort profiles at baseline in the Macmillan HORIZONS Programme - Claire Foster
• Worry and uncertainty related to long-term effects of prostate cancer treatment: A qualitative exploration - Ilona Juraskova
• An exploration of the perceptions, experience and practice of cancer clinicians in caring for young patients with malignancy who are also parents - Sarah Heynemann
• Using podcasts to deliver information and support after a diagnosis of metastatic disease - Elizabeth Humphries
• Establishing a Nurse Led Prostate Specific Antigen (PSA) Phone Clinic. Keeping men empowered with supportive care. - Judy Jeffery
• Clinical practice guideline for Vaccination of the immunocompromised host after autologous HSCT in an oncology day hospital - Kate Kim
• Australian Cancer Clinicians’ Awareness, understanding and perceptions regarding cancer-related malnutrition and sarcopenia - Nicole Kiss
• The lived experiences of colorectal cancer survivors: A systematic review of qualitative research. - Chloe Y. S. Lim
• Optimising the cancer nutrition path: co-design of a cancer nutrition care pathway by patients, carers and health professionals - Jenelle Loeliger
• CanDo - Turn empathy into action - Rachael Lonergan
• Factors affecting resilience in patients with colorectal cancer: a qualitative study - Dan Luo
• A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. - Megan McIntosh
• Cancer Australia Statement: Influencing best practice in metastatic breast cancer - Vivienne Milch
• Life after cancer: Facilitated group exercise programs for adolescents and young adults. - Claire Munsie
• Diet quality, physical activity levels and other health behaviours in long-terms survivors of adolescent and young adult (AYA) cancer. - Andrew Murnane
• Health-related quality of life and fatigue levels in Australian adolescent and young adult (AYA) cancer survivors. - Andrew Murnane
• What are the attitudes of health professionals regarding Patient Reported Outcome Measures in oncology? A mixed-method synthesis of the qualitative evidence - Brona Nic Giolla Easpaig
• Older People with Cancer, helping us to help them: a Wimmera Supportive Care Experience. - Carmel O'Kane
• Antimicrobial usage reporting in the oncology day hospital setting - Margaret Patterson
• Male callers to Cancer Council SA’s 13 11 20: Current utilisation patterns and ways to address unmet information and support needs - Amanda Robertson
• A patient-reported outcome (PRO) assessment model for colorectal cancer (CRC) survivors: a mixed methods systematic review. - Claudia Rutherford
• Detection of delirium in admitted oncology patients: a scoping review - Megan B. Sands
• Accessing psycho-oncology services: A systematic review of factors influencing the help seeking decisions of cancer patients with co-morbid anxiety and depression. - Joanne Shaw
• Dietary and weight management support needs of women diagnosed with premenopausal breast cancer - Zoe Thomson
• Prehabilitation for colorectal cancer prior to surgery – a feasibility study. - Janette L Vardy
• Differences in experiences and preferences for cancer treatment decision making among patients undergoing radiotherapy in Australia, Japan and Vietnam     - Megumi Uchida
• Recognising the Dying Patient: A Retrospective Audit of Systemic Anti-Cancer Therapy Administration to Oncology Patients in the Month Prior to Death, Results from a Tertiary Australian centre. - Arielle van Mourik
• Evaluation of Survivorship Care Plans in survivors attending the Sydney Cancer Survivorship Centre (SCSC) clinic - Janette Vardy
• Nutritional risk screening and risk factors analysis in patients with lymphoma undergoing chemotherapy: a prospective study - Yishu Wang
• The role of comorbidity assessment in guiding treatment decision-making for women with early breast cancer: a systematic literature review - Stephanie Webster
• Patient Preferences for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Australia (mCRPC): a Discrete Choice Experiment. - Wendy R Winnall
• Physical Activity and Metastatic Breast Cancer: Preferences and Barriers - Jasmine Yee

• Overlooked minorities: the intersection of cancer in lesbian, gay, bisexual, transgender and/or intersex (LGBTI) adolescents and young adults - Mairghread Clarke
• Cancer and gender-affirming hormone therapy in transgender individuals  - Ada Cheung
• Unmet needs of gender and sexually diverse people with cancer  - Micah Peters

• Improving outcomes for rural cancer survivors: reflections from a Churchill Fellowship - Kate M Gunn
• Implementation of teleoncology models of care within health systems   - Sabe Sabesan
• Delivering the best and most technologically advanced treatment for cancer patients regardless of their address  - Michael Penniment
• Contemporary cancer care coordination: Better rural patient outcomes  - Peggy Briggs